ValueAct Capital (VAC) is an American investment management firm based in San Francisco, California.
History
In August 2022, ValueAct Capital acquired a 7% stake in The New York Times Company.[1]
Portfolio
Companies in VAC's portfolio include:[2]
- 21st Century Fox
- Acxiom
- Adobe
- Advanced Medical Optics
- Agilent Technologies
- Alere
- American Tower
- Amicas
- Applied Biosystems
- Avention
- Baker Hughes
- Bausch Health
- Bioverativ
- Bread Financial
- Catalina
- CBRE Group
- Chiron Corporation
- Citigroup
- C.R. Bard
- Dresser-Rand
- Element Fleet Management
- Equifax
- Fidelity National Financial (FNF)
- Finastra
- First Health Group
- Fiserv
- Halliburton
- Illumina
- Immucor
- Intergraph
- JSR Corporation
- Kohlberg Kravis Roberts (KKR)
- Life Technologies
- Lifeline Systems
- Lincare
- Martha Stewart Living Omnimedia
- McAfee
- MDS
- MedQuist
- Mentor
- Microsoft
- Moody's
- Morgan Stanley
- Motorola Solutions
- MSC Software
- MSCI
- New York Times Company
- Nintendo
- Omnicare
- Per-Se Technologies
- PRA International
- Redwood Trust
- Reuters Group
- Reynolds and Reynolds
- Rockwell Collins
- Rolls-Royce Holdings
- Salesforce
- Sallie Mae
- Seven & I Holdings
- Spotify
- Ströer
- Topcon
- Trend Micro
- Trinity Industries
- TriZetto
- Verisign
- Warner Chilcott
- Willis Towers Watson (WTW)
External links
Deveau, S. (2022, August 11). New York Times Is Targeted by Activist Investor Pushing for Subscriber-Only Bundles. Bloomberg. http://archive.today/2022.08.11-175631/https://www.bloomberg.com/news/articles/2022-08-11/activist-investor-valueact-takes-7-stake-in-new-york-times ↩︎
Companies. ValueAct Capital. Retrieved November 2, 2023, from https://web.archive.org/web/20231102194714/https://valueact.com/companies/ ↩︎
